IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.800
NA - Nord America 3.744
AS - Asia 2.647
SA - Sud America 512
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 117
OC - Oceania 14
Totale 11.040
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.580
RU - Federazione Russa 1.059
SG - Singapore 801
IE - Irlanda 751
IT - Italia 617
CN - Cina 466
VN - Vietnam 406
BR - Brasile 367
HK - Hong Kong 352
DE - Germania 315
SE - Svezia 293
FR - Francia 196
UA - Ucraina 186
IN - India 140
GB - Regno Unito 100
CA - Canada 98
BD - Bangladesh 85
FI - Finlandia 84
KR - Corea 77
ID - Indonesia 71
AR - Argentina 53
NL - Olanda 43
TR - Turchia 42
MX - Messico 34
BJ - Benin 32
JP - Giappone 32
ZA - Sudafrica 31
IR - Iran 29
IQ - Iraq 28
PK - Pakistan 28
AT - Austria 27
ES - Italia 27
PL - Polonia 26
EC - Ecuador 23
CL - Cile 22
CZ - Repubblica Ceca 22
MY - Malesia 20
AU - Australia 14
TH - Thailandia 13
VE - Venezuela 13
PY - Paraguay 12
PE - Perù 11
TW - Taiwan 10
CH - Svizzera 9
EG - Egitto 9
LT - Lituania 9
CO - Colombia 8
KE - Kenya 8
MA - Marocco 8
PH - Filippine 8
BE - Belgio 7
NG - Nigeria 7
IL - Israele 6
TT - Trinidad e Tobago 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
HN - Honduras 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
TN - Tunisia 4
CR - Costa Rica 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BM - Bermuda 2
CU - Cuba 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
NO - Norvegia 2
PR - Porto Rico 2
SI - Slovenia 2
SV - El Salvador 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
Totale 10.829
Salva come PNG Salva come JPEG
Città #
Dublin 739
San Jose 491
Hong Kong 336
Singapore 335
Council Bluffs 311
Jacksonville 310
Ashburn 259
Columbus 172
Moscow 136
Beijing 130
Ho Chi Minh City 110
Lauterbourg 105
Los Angeles 100
Chandler 99
Hanoi 87
Lawrence 82
Princeton 82
Wilmington 72
New York 71
San Mateo 69
Novara 63
Santa Clara 60
Jakarta 55
Dearborn 54
Seoul 53
Munich 52
Milan 51
Piemonte 49
Buffalo 45
Helsinki 43
Turin 43
Orem 42
São Paulo 39
Dallas 38
Dong Ket 36
Frankfurt am Main 34
Chennai 33
Cotonou 32
Montreal 32
Bremen 27
Nuremberg 26
Ann Arbor 25
Vercelli 25
Redondo Beach 24
Toronto 24
Boardman 22
Denver 22
Warsaw 22
Andover 21
Brooklyn 21
Rome 21
Tokyo 21
Philadelphia 20
Amsterdam 19
Brno 19
London 19
Houston 18
Johannesburg 18
Da Nang 17
Falkenstein 17
Mexico City 17
Phoenix 17
Boston 16
Norwalk 16
Stockholm 16
Vienna 16
Chicago 14
Monmouth Junction 13
Poplar 13
Rio de Janeiro 13
Haiphong 12
Hangzhou 12
Istanbul 12
Santiago 12
Atlanta 11
Augusta 11
Dhaka 11
Guangzhou 11
Shanghai 11
Tianjin 11
Ankara 10
Bologna 10
Kocaeli 10
Mumbai 10
Paris 10
West Jordan 10
Ardabil 9
Baghdad 9
Guayaquil 9
The Dalles 9
Alessandria 8
Brasília 8
Charlotte 8
City of London 8
Fairfield 8
Gangbuk-gu 8
Kuala Lumpur 8
Manchester 8
Nairobi 8
Nanjing 8
Totale 5.839
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 400
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 194
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 181
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 176
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 172
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 170
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 168
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 148
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 143
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 142
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 142
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 138
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 134
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 132
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 131
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 130
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 129
Chronic hepatitis C is mild in menstruating women 128
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 126
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 123
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 118
CYP2E1 autoantibodies in liver diseases 117
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 116
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 115
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 114
Elastography in Liver-Transplanted Patients 114
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 113
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 113
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 112
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 111
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 109
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 108
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 108
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 106
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 106
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 105
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 105
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 103
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 101
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 101
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 100
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 99
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 98
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 97
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 96
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 96
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 95
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 95
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 94
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 91
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 91
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 88
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 85
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 84
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 84
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 84
Gender and liver fibrosis in chronic hepatitis: the role of iron status 83
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 81
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 81
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 79
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 79
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 79
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 78
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 77
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 77
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 77
Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis 77
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 76
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 76
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 76
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 75
Do not trivialize the Fibroscan® examination, value its accuracy 74
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 74
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 74
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 73
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 73
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 73
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 72
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 70
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 70
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 70
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 70
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 69
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 68
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 67
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 66
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 66
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 65
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 65
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 65
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 63
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 63
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 63
Spleen stiffness in portal hypertension algorithms: the next advance 62
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 62
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 62
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 61
Totale 10.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022596 0 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/20251.568 30 25 110 41 56 158 215 177 324 102 67 263
2025/20265.106 203 169 310 685 454 347 781 819 364 502 299 173
2026/2027616 244 372 0 0 0 0 0 0 0 0 0 0
Totale 11.040